首页> 外文期刊>Nucleic Acids Research >Mechanistic analyses of site-specific degradation in DNA-RNA hybrids by prototypic DNA cleavers.
【24h】

Mechanistic analyses of site-specific degradation in DNA-RNA hybrids by prototypic DNA cleavers.

机译:原型DNA切割器对DNA-RNA杂种中特定位点降解的机理分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Bleomycin (BLM) binding and chemistry are apparently sensitive to differences in nucleic acid conformation and could conceivably be developed as a probe for sequence-dependent elements of conformation. We report on the development of a new methodology to synthesize heterogeneous DNA-RNA hybrids of defined sequence and present the results of our comparative studies on the cleavage of DNA and DNA-RNA hybrids by four drugs: BLM, neocarzinostatin and esperamicins A1 and C. In the case of BLM with duplex DNA, purine-pyrimidine steps such as GT and GC, are consistently hit, as previously observed. However, in heterogeneous sequence hybrids, not all GC sites are recognized by the drug, although all GT sites are. Suppressed GC sites are consistently flanked by pyrimidines on both the 3' and 5' sides, suggesting that the BLM binding site in hybrids spans at least four bases. Kinetic isotope studies with specifically deuterated substrates (kH/kD = 1.2-4.0) and the effect of oxygen on the product profile are presented in support of a mechanism consistent with 4'-hydrogen abstraction in hybrids. The powerful double-labeled probe technique was extended to study the mechanism of action of other DNA degrading drugs on DNA-RNA hybrids. For neocarzinostatin, the sequence specificity lies in the AT-rich region for hybrids and is similar to that of DNA, however, the overall cleavage pattern for the hybrid is significantly different from that for the same sequence of DNA. In the hybrid, a stretch of AT residues is essential and the A sites are damaged to a greater extent than they are in DNA. However, no kinetic isotope effects are observed and, based on the product profile, the mechanism of degradation of the DNA strand of hybrids seems to be limited to abstraction of the 5'-hydrogen. For esperamicin A1, damage on the DNA strand of hybrids occurs exclusively via 5'-hydrogen abstraction in a non-rate determining step and primarily at A and T sites. Esperamicin C behaves similarly, exhibiting no isotope effects at 1', 4' and 5' positions. Overall, the differences observed in site-specific cleavage between the two substrates is proposed to be a result of conformational differences between the DNA strand of duplex DNA and DNA-RNA hybrids.
机译:博来霉素(BLM)的结合和化学作用显然对核酸构象的差异敏感,可以想象将其开发为构象的序列依赖性元件的探针。我们报告了一种新方法的发展,该方法可合成确定序列的异质DNA-RNA杂合体,并介绍了我们对四种药物对DNA和DNA-RNA杂合体进行裂解的比较研究结果:BLM,新carcarinostatin和esperamicins A1和C.如前所述,在具有双链DNA的BLM情况下,嘌呤-嘧啶步骤(例如GT和GC)始终受到打击。但是,在异质序列杂种中,尽管所有GT位点均可识别,但并非所有GC位点都能被药物识别。抑制的GC位点始终在3'和5'侧均被嘧啶侧翼,这表明杂种中的BLM结合位点至少跨越四个碱基。提出了具有特定氘代底物(kH / kD = 1.2-4.0)的动力学同位素研究以及氧对产物谱的影响,以支持与杂化物中4'-氢提取相一致的机理。强大的双标记探针技术被扩展为研究其他DNA降解药物对DNA-RNA杂种的作用机理。对于新卡司他汀,序列特异性位于杂种的AT富集区域,与DNA相似,但是,杂种的整体切割模式与相同DNA序列的显着不同。在杂种中,一段AT残基是必不可少的,而且A位点的破坏程度要比DNA中更大。然而,没有观察到动力学同位素效应,并且基于产物概况,杂种的DNA链的降解机制似乎仅限于提取5'-氢。对于埃斯帕米霉素A1,仅在非速率确定步骤中主要通过A和T位点通过5'-氢提取对杂种的DNA链造成破坏。埃斯帕霉素C的行为相似,在1',4'和5'位置无同位素效应。总的来说,两种底物之间在位点特异性切割上观察到的差异被认为是双链DNA和DNA-RNA杂交体DNA链构象差异的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号